Epitalon

What it is

Epitalon is a synthetic chain of four amino acids, alanine, glutamic acid, aspartic acid, and glycine, modeled on a peptide the pineal gland produces naturally. Chemists classify it as a tetrapeptide, one of the smallest peptides studied in longevity research. The Russian scientist Vladimir Khavinson first described it, and it has since appeared in the scientific literature for more than three decades, mostly through research groups working in Russia.

Much of the interest in epitalon centers on telomerase, an enzyme cells use to rebuild the protective caps, called telomeres, on the ends of their chromosomes. Some researchers have proposed that epitalon can switch this enzyme on in certain cell types under laboratory conditions. Separate work has looked at whether it changes which genes are active and at its relationship with melatonin, a hormone the pineal gland also makes. These remain proposed lines of inquiry rather than settled science.

How it is studied

Published work on epitalon spans laboratory cell studies and a small number of human observations, most of it originating from research groups in Russia over several decades. Cell studies have looked at what happens when the peptide is added directly to human cells grown in a dish, including stem cells taken from gum tissue. Separate reports have measured outcomes in people already being treated for an unrelated eye condition. There is no broad program of large, independently repeated human trials confirming these effects.

What studies report

• In one study, researchers exposed human gum-derived stem cells to epitalon and found that several genes tied to nerve-cell development became more active than in untreated cells [1]. [1]
• An earlier study reported that adding epitalon to human cells grown in a dish turned on telomerase activity and let those cells divide many more times before stopping compared with untreated cells [2]. [2]

What is not known

Only two independently verifiable published sources are cited in this entry, and both are laboratory cell studies. Other effects often discussed for epitalon, including animal lifespan work and clinical observations beyond the eye-condition report, circulate widely in secondary writing, but the underlying papers could not be independently confirmed for this profile and so are not reported here. Whether the telomerase changes seen in cells grown in a dish carry over to a whole living body, let alone to people, is not established by these two papers on their own. Both studies also involve small numbers of cells or subjects rather than large, repeated trials.

Regulatory status

Epitalon has not been approved by the United States Food and Drug Administration or by any other national medicines regulator for use in people. It does not appear on the World Anti-Doping Agency list of prohibited substances. In the published record it exists purely as an experimental compound studied in cells and, to a much smaller extent, in people, not as an approved medicine.